Filing Flows › BioMarin Pharmaceutical (BMRN) › Recalls, complaints & regulation
BioMarin Pharmaceutical (BMRN): clinical trials and Federal Register
BioMarin Pharmaceutical (BMRN) beyond its filings: 2 Federal Register documents in a year; 26 active clinical trials.
BioMarin Pharmaceutical's latest quarter
BioMarin Pharmaceutical, Q3 2026: revenue $1.0B (+32% year over year), operating margin -8.0%, net loss $123M, operating cash flow $188M. The chart follows the revenue to costs, profit and cash.
Questions
How many clinical trials does BioMarin Pharmaceutical have?
26 active studies on ClinicalTrials.gov, 6 in phase 3.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.